Awaiting product image

Ihc – Breast Cancer Prognosis Basic Panel (Er, Pr)

₹3,000.00

15 minutes
Categories: ,

This test uses Immunohistochemistry (IHC) to detect the presence of Estrogen Receptors (ER) and Progesterone Receptors (PR) in breast cancer tissue. These hormone receptors are proteins found inside or on the surface of certain breast cancer cells that bind to estrogen or progesterone, fueling tumor growth.

Detecting the presence or absence of these receptors helps in identifying hormone receptor-positive breast cancers, which typically respond well to hormone (endocrine) therapy.

Enquiry Here

    Description

    Why It’s Done:

    The IHC – Breast Cancer Prognosis Basic Panel is performed to:
    • Determine hormone receptor status of breast cancer (ER and/or PR positive or negative).
    • Guide treatment decisions—patients with ER/PR-positive tumors often benefit from hormone therapy such as tamoxifen or aromatase inhibitors.
    • Predict the behavior and prognosis of the cancer; hormone receptor-positive cancers tend to grow more slowly and have a better prognosis.
    • Help stratify patients for personalized treatment plans.

    Preparation:

    • No special preparation is required for the test itself.
    • It is performed on a breast tissue sample, typically obtained during a biopsy or surgery.
    • Pre-biopsy instructions should be followed if applicable (e.g., fasting, medication guidelines).
    • Inform your doctor about any medications or health conditions, especially if you are scheduled for a biopsy procedure.

    Related products